Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ZYPITAMAG 4 MG TABLET

Pitavastatin Magnesium
$7.3997per EA

Strength

4 mg/1

Manufacturer

Medicure International Inc

NDC

25208020215

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PITAVASTATIN

Approval Type

New Drug (NDA)

FDA Application

NDA208379

On Market Since

3/9/2018

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

-0.0%

6M

-0.2%

1Y

-0.3%

3Y

N/A

5Y

N/A

All

-0.0%

Generic Alternatives

1 alternative • Same active ingredient

ZYPITAMAG 4 MG TABLET
Brand
25208020209•Medicure International Inc
$7.3997

Related Drugs

Same classification

ATORVALIQ 20 MG/5 ML SUSP
Brand
46287003001•CMP Pharma, Inc.
$1.1894
per ML
CRESTOR 20 MG TABLET
Brand
00310758090•AstraZeneca Pharmaceuticals LP
$8.8120
per EA
CRESTOR 5 MG TABLET
Brand
00310756090•AstraZeneca Pharmaceuticals LP
$8.8167
per EA
CRESTOR 10 MG TABLET
Brand
00310757090•AstraZeneca Pharmaceuticals LP
$8.8175
per EA
CRESTOR 40 MG TABLET
Brand
00310759030•AstraZeneca Pharmaceuticals LP
$8.8184
per EA
ZOCOR 20 MG TABLET
Brand
78206018101•Organon LLC
$9.7276
per EA
ZOCOR 20 MG TABLET
Brand
78206018102•Organon LLC
$9.7276
per EA
ZOCOR 40 MG TABLET
Brand
78206018201•Organon LLC
$9.7294
per EA
ZOCOR 40 MG TABLET
Brand
78206018202•Organon LLC
$9.7294
per EA
LESCOL XL 80 MG TABLET
Brand
66758021131•Sandoz Inc.
$13.0643
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy